The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers
- PMID: 38002031
- PMCID: PMC10669604
- DOI: 10.3390/biomedicines11113031
The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers
Abstract
The prevalence of multiple sclerosis (MS) has been increasing among young people in developing countries over the last years. With the continuous development of new technology, the diagnosis and follow-up of these patients has received new parameters that physicians may use in their practice. This paper reviews the main biomarkers identified through Optical Coherence Tomography Angiography (OCT-A) involved in the development and progression of MS and investigates the role it may have in detecting changes to the central nervous system (CNS).
Keywords: OCT; OCT-A; demyelinating disease; multiple sclerosis; optical coherence tomography; optical coherence tomography angiography; retinal vascular density.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Hittle M., Culpepper W.J., Langer-Gould A., Marrie R.A., Cutter G.R., Kaye W.E., Wagner L., Topol B., LaRocca N.G., Nelson L.M., et al. Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic Region. JAMA Neurol. 2023;80:693. doi: 10.1001/jamaneurol.2023.1135. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources